Publicaciones del Grupo de Investigación

Miembros del Grupo

Líneas de investigación

Artículos

Proyectos

Otras publicaciones

A un Clic

Búsquedas

Epidemiología y Salud Pública

Miembros del Grupo

Líneas de investigación

Artículos

Proyectos

Otras publicaciones

AÑO:

TOTAL Nº PUBLICACIONES: 28
TOTAL FACTOR IMPACTO: 85,608

Albajar M, Gómez-Casares MT, Llorca J, Mauleon I, Vaqué JP, Acosta JC, Bermúdez A, Donato N, Delgado MD, León J. MYC in chronic myeloid leukemia: induction of aberrant DNA synthesis and association with poor response to imatinib. Mol. Cancer Res. 2011; 9:564-576. F.I.: 4,373

Alonso MD, Llorca J, Martinez-Vazquez F, Miranda-Filloy JA, Diaz de Teran T, Dierssen T, Vazquez-Rodriguez TR, Gomez-Acebo I, Blanco R, Gonzalez-Gay MA. Systemic lupus erythematosus in northwestern Spain: a 20-year epidemiologic study. Medicine (Baltimore) 2011; 90:350-358. F.I.: 4,256

Amor-Dorado JC, Barreira-Fernandez MP, Vazquez-Rodriguez TR, Gomez-Acebo I, Miranda-Filloy JA, Diaz de Teran T, Llorca J, Gonzalez-Gay MA. Audiovestibular manifestations in patients with ankylosing spondylitis. Medicine (Baltimore) 2011; 90:99-109. F.I.: 4,256

Amor-Dorado JC, Barreira-Fernández MP, Vázquez-Rodríguez TR, Miranda-Filloy JA, Llorca J, González-Gay MA. Benign paroxysmal positional vertigo and clinical test of sensory interaction and balance in ankylosing spondylitis. Otol. Neurotol. 2011; 32:278-283. F.I.: 2,065

Arbaizar B, Llorca J. Hipertiroidismo inducido por la ingestión de Fucus vesiculosus en un paciente en tratamiento concomitante con litio. Actas Esp. Psiquiatri. 2011; 39:401-403. F.I.: 0,695

Castellanos-Ortega A, Suberviola B, García-Astudillo LA, Ortiz F, Llorca J, Delgado-Rodríguez M. Late compliance with the sepsis resuscitation bundle: impact on mortality. Shock 2011; 36:542-547. F.I.: 3,203

García-Bermúdez M, González-Juanatey C, Rodríguez-Rodríguez L, Miranda-Filloy JA, Perez-Esteban S, Vazquez-Rodriguez TR, Castañeda S, Balsa A, Fernández-Gutierrez B, Llorca J, González-Alvaro I, Martín J, González-Gay MA. Lack of association of NAMPT rs9770242 and rs59744560 polymorphisms with disease susceptibility and cardiovascular risk in patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 2011; 29:681-688. F.I.: 2,358

García-Bermúdez M, González-Juanatey C, Rodríguez-Rodríguez L, Vazquez-Rodriguez TR, Miranda-Filloy JA, Fernández-Gutierrez B, Llorca J, Martin J, González-Gay MA. Lack of association between LEP rs2167270 (19 G>A) polymorphism and disease susceptibility and cardiovascular disease in patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 2011; 29:293-298. F.I.: 2,358

Gómez-Acebo I, Llorca J, Ortiz-Revuelta C, Angulo B, Gómez-Álvarez S, Dierssen-Sotos T. Sick building syndrome in a general hospital and the risks for pregnant workers. Int. J. Gynecol. Obstet. 2011; 113:241-242. F.I.: 1,704

González-Castro A, Suárez-Lopez V, Gómez-Marcos V, González-Fernandez C, Iglesias-Posadilla D, Burón-Mediavilla J, Rodríguez-Borregan JC, Miñambres E, Llorca J. Valor de la fracción de espacio muerto (Vd/Vt) como predictor de éxito en la extubación. Med. Intensiv. 2011; 35:529-538. F.I.: 1,496

Gonzalez-Gay MA, Gonzalez-Juanatey C, Llorca J. Subclinical atherosclerosis in ankylosing spondylitis. J. Rheumatol. 2011; 38:2073-2073. F.I.: 3,551

Gonzalez-Gay MA, Gonzalez-Juanatey C, Miranda-Filloy JA, Martin J, Garcia-Unzueta MT, Llorca J. Response to 'Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomized study over 21 months'. Arthritis Res. Ther. 2011; 13:404-404. F.I.: 4,357

Gonzalez-Gay MA, Gonzalez-Juanatey C, Rodriguez-Rodriguez L, Miranda-Filloy JA, Martin J, Llorca J. Lack of association between adipokines and ghrelin and carotid intima-media thickness in patients with severe rheumatoid arthritis. Clin. Exp. Rheumatol. 2011; 29:358-359. F.I.: 2,358

González-Juanatey C, Llorca J, González-Gay MA. Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease. Arthritis Res. Ther. 2011; 13:0-0. F.I.: 4,357

Ide MR, Gonzalez-Gay MA, Yano KC, Imai MJ, de Andrade MC, Llorca J. Functional capacity in rheumatoid arthritis patients: comparison between Spanish and Brazilian sample. Rheumatol. Int. 2011; 31:221-226. F.I.: 1,431

López-Mejías R, García-Bermúdez M, González-Juanatey C, Castañeda S, Miranda-Filloy JA, Gómez-Vaquero C, Fernández-Gutiérrez B, Balsa A, Pascual-Salcedo D, Blanco R, González-Álvaro I, Llorca J, Martín J, González-Gay MA. Lack of association of IL6R rs2228145 and IL6ST/gp130 rs2228044 gene polymorphisms with cardiovascular disease in patients with rheumatoid arthritis. Tissue Antigens 2011; 78:438-441. F.I.: 3,024

López-Mejías R, García-Bermúdez M, González-Juanatey C, Castañeda S, Pérez-Esteban S, Miranda-Filloy JA, Gómez-Vaquero C, Fernández-Gutiérrez B, Balsa A, Pascual-Salcedo D, Blanco R, González-Álvaro I, Llorca J, Martín J, González-Gay MA. Lack of association between IL6 single nucleotide polymorphisms and cardiovascular disease in Spanish patients with rheumatoid arthritis. Atherosclerosis 2011; 219:655-658. F.I.: 4,086

Martinez-Lado L, Calviño-Díaz C, Piñeiro A, Dierssen T, Vazquez-Rodriguez TR, Miranda-Filloy JA, Lopez-Diaz MJ, Blanco R, Llorca J, Gonzalez-Gay MA. Relapses and recurrences in giant cell arteritis: a population-based study of patients with biopsy-proven disease from northwestern Spain. Medicine (Baltimore) 2011; 90:186-193. F.I.: 4,256

Ortego C, Huedo-Medina TB, Llorca J, Sevilla L, Santos P, Rodríguez E, Warren MR, Vejo J. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS behav. 2011; 15:1381-1396. F.I.: 3,195

Ortego C, Huedo-Medina TB, Vejo J, Llorca FJ. Adherence to highly active antiretroviral therapy in Spain. A meta-analysis. Gac. Sanit. 2011; 25:282-289. F.I.: 1,114

Rodríguez-Rodríguez L, Carmona FD, Castañeda S, Miranda-Filloy JA, Morado IC, Narváez J, Marí-Alfonso B, Gómez-Vaquero C, Amigo-Díaz E, Ríos-Fernández R, Blanco R, Llorca J, Fernández-Gutiérrez B, Martín J, González-Gay MA. Role of rs1343151 IL23R and rs3790567 IL12RB2 polymorphisms in biopsy-proven giant cell arteritis. J. Rheumatol. 2011; 38:889-892. F.I.: 3,551

Rodriguez-Rodriguez L, Garcia-Bermudez M, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Fernandez-Gutierrez B, Llorca J, Martin J, Gonzalez-Gay MA. Lack of association between RETN rs1862513 polymorphism and cardiovascular disease in rheumatoid arthritis patients. Clin. Exp. Rheumatol. 2011; 29:19-25. F.I.: 2,358

Rodríguez-Rodríguez L, García-Bermúdez M, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Fernandez-Gutierrez B, Llorca J, Martin J, Gonzalez-Gay MA. Analysis of the influence of the ghrelin receptor rs509035, rs512692 and rs2922126 polymorphisms in the risk of cardiovascular disease in patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 2011; 29:142-143. F.I.: 2,358

Rodríguez-Rodríguez L, García-Bermúdez M, González-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Fernandez-Gutierrez B, Llorca J, Martin J, González-Gay MA. Lack of association between ADIPOQ rs266729 and ADIPOQ rs1501299 polymorphisms and cardiovascular disease in rheumatoid arthritis patients. Tissue Antigens 2011; 77:74-78. F.I.: 3,024

Rodríguez-Rodríguez L, García-Bermúdez M, González-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Fernández-Gutierrez B, Llorca J, Martín J, González-Gay MA. Vascular endothelial growth factor A and cardiovascular disease in rheumatoid arthritis patients. Tissue Antigens 2011; 77:291-297. F.I.: 3,024

Rodríguez-Rodríguez L, González-Juanatey C, García-Bermúdez M, Vázquez-Rodríguez TR, Miranda-Filloy JA, Fernández-Gutiérrez B, Llorca J, Martin J, González-Gay MA. CCR5?32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study. Arthritis Res. Ther. 2011; 13:0-0. F.I.: 4,357

Rodríguez-Rodríguez L, González-Juanatey C, Palomino-Morales R, Vázquez-Rodríguez TR, Miranda-Filloy JA, Fernández-Gutiérrez B, Llorca J, Martin J, González-Gay MA. TNFA -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis. Atherosclerosis 2011; 216:125-130. F.I.: 4,086

Teruel M, Martin JE, González-Juanatey C, López-Mejias R, Miranda-Filloy JA, Blanco R, Balsa A, Pascual-Salcedo D, Rodriguez-Rodriguez L, Fernández-Gutierrez B, Ortiz AM, González-Alvaro I, Gómez-Vaquero C, Bottini N, Llorca J, González-Gay MA, Martin J. Association of acid phosphatase locus 1*C allele with the risk of cardiovascular events in rheumatoid arthritis patients. Arthritis Res. Ther. 2011; 13:0-0. F.I.: 4,357